Old Web
English
Sign In
Acemap
>
authorDetail
>
Paul A. Foster
Paul A. Foster
University of Southern California
Medicine
Immunology
Rituximab
Ibritumomab tiuxetan
Nuclear medicine
6
Papers
109
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Change in T and NK Cell Counts
2008
Jennifer A. Woyach
Farrukh T. Awan
Ian W. Flinn
Jesus G. Berdega
Elizabeth Wiley
Sharmeen Mansoor
Ying Huang
Gerard Lozanski
Paul A. Foster
John C. Byrd
Show All
Source
Cite
Save
Citations (0)
The Role of Imaging with 111In-Ibritumomab Tiuxetan in the Ibritumomab Tiuxetan (Zevalin) Regimen: Results from a Zevalin Imaging Registry
2005
The Journal of Nuclear Medicine
Peter S. Conti
Christine A. White
Peter C. Pieslor
Arturo Molina
Jacqueline Aussie
Paul A. Foster
Show All
Source
Cite
Save
Citations (54)
Low frequency of altered biodistribution detected by Indium-111 imaging prior to yttrium-90 ibritumomab tiuxetan radioimmunotherapy: Imaging registry results
2005
Journal of Clinical Oncology
Peter S. Conti
Christine A. White
Peter C. Pieslor
G. Menéndez
V. D. Harrough
Dan Matso
Jacqueline Aussie
T Ryskamp
Paul A. Foster
Show All
Source
Cite
Save
Citations (0)
Incidence of Altered Biodistribution Detected by Indium 111 ( 111 In) Imaging Prior to Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy: Results from a Zevalin Imaging Registry.
2004
Blood
Peter S. Conti
Christine White
Peter Pieslor
Gene Menendez
V. Douglas Harrough
Dan Matso
Jacqueline Aussie
Thomas Ryskamp
Paul A. Foster
Show All
Source
Cite
Save
Citations (2)
1